TF and pancreatic neoplasm: Pancreatic cancer is considered to be a highly prothrombotic malignancy [12], and elevated levels of MV-associated TF-activity in these patients have been associated with an increased risk of mortality [13, 14], a more aggressive, invasive phenotype [15] and VTE [14, 16–18].